Mr Macdonald most recently served as president and CEO at Nanomix. He also served as president and COO of Nichols Institute Diagnostics, a division of Quest Diagnostics and as president and CEO of Progeny Systems and Medical Electronic Systems.
Francois Ferre, co-president and co-CEO of Althea, said: “We are extremely delighted to have such a seasoned leader in the diagnostics field join Althea Diagnostics. Mr David brings to the new company not only a demonstrated ability to translate diverse technologies into innovative products, but also a track record of making those products successful worldwide.”